PRTN3 and rheumatoid arthritis: As it has been suggested that the pathogenesis of ACPA negative RA differs from ACPA positive RA [16–18] and that immune cell involvement is linked to autoantibody status [19, 20] we aimed to investigate whether the molecular and cellular landscape in lymphoid organs differs between ACPA positive RA patients and ACPA negative IA patients.